(19)
(11) EP 2 427 442 A1

(12)

(43) Date of publication:
14.03.2012 Bulletin 2012/11

(21) Application number: 10719756.8

(22) Date of filing: 07.05.2010
(51) International Patent Classification (IPC): 
C07D 271/12(2006.01)
A61K 31/4245(2006.01)
A61K 31/7076(2006.01)
A61P 31/16(2006.01)
 C07D 417/04(2006.01)
A61K 31/427(2006.01)
C07H 19/167(2006.01)
(86) International application number:
PCT/EP2010/056294
(87) International publication number:
WO 2010/128156 (11.11.2010 Gazette 2010/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 08.05.2009 WO PCT/EP2009/055633

(71) Applicant: Pike Pharma GmbH
8005 Zürich (CH)

(72) Inventors:
  • KESSLER, Ulrich
    CH-8005 Zürich (CH)
  • RANADHEERA, Charlene
    CH-8005 Zürich (CH)

(74) Representative: Kälin, Moritz Andreas 
Rentsch Partner AG Rechtsanwälte und Patentanwälte Fraumünsterstrasse 9 Postfach 2441
8022 Zürich
8022 Zürich (CH)

   


(54) 2,1,3-BENZOXADIAZOL DERIVATIVES FOR THE INHIBITION OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION